BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. DNMT1, T cell differentiation, Lung cancer, Neuron, Early pregnancy factor, Rapamycin)
Bookmark Forward

QuickView for serine proteases (compound)


Genetic Markers

Most Correlated Genes

  1. PLAUR
  2. CXCL6
  3. MKI67
  4. EPCAM
  5. F9
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. cellular aromatic compound metabolic process
  2. nucleolus
  3. organic cyclic compound metabolic process
  4. heterocycle metabolic process
  5. RNA binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drosophila melanogaster larval midgut gene expression after Bowman-Birk inhbitor exposure
  2. Direct effects of IL-13 on Airway Epithelial Cells
  3. Lung expression in Foxa3 knock-out and wildtype mice challenged with allergen
  4. Effect of Protease-resistant PML-RARA and normal PML-RARA expression in a lymphoma cell line
  5. Osteoblast (UMR106-1) gene expression after treatment with beta-glycerol phosphate (BPG) and AEB
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Natural proteinaceous inhibitors of serine proteases.
  2. Serine protease from midgut of Bombus terrestris males.
  3. Inhibition of the serine proteases of the complement system.
  4. A new serine protease from the leaves of Thespesia populnea.
  5. The long road of research on snake venom serine proteinases.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
  2. RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
  3. Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 …
  4. Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
  5. STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.